Fabrice Chouraqui to become CEO of Pharming 

Fabrice Chouraqui will become CEO of Pharming Group N.V. (Euronext:PHARM) pending the approval of the company’s shareholders at a March 4 extraordinary meeting. Chouraqui, a CEO-partner of Flagship Pioneering, will succeed Sijmen de Vries if approved. 

Friends of Cancer Research appointed FDA veteran Janet Woodcock and attorney Paul Kim to its board. Woodcock was most recently acting FDA commissioner, then principal deputy commissioner at the agency; Kim led the FDA and federal government strategies practices at Foley Hoag LLP, where he worked for 20 years. ...